• About Us
    • Fact Checking Policy
    • Ownership & funding information
    • Volunteer
  • Subscribe
  • Letter submission
    • Submissions Policy
  • Contact Us
The Online Citizen Asia
  • Opinion
    • Editorial
    • Commentaries
    • Letters
    • Comments
  • Current Affairs
    • Singapore
    • Malaysia
    • Indonesia
    • China
    • ASEAN
    • Asia
    • International
  • Finance
    • Economics
    • Labour
    • Property
    • Business
  • Community
    • Arts & Culture
    • Consumer Watch
    • NGO
    • Lifestyle
    • Travel
  • Politics
    • Civil Society
    • Parliament
    • Transport
    • Education
    • Environment
    • Health
    • Housing
  • Law & Order
    • Legislation
    • Court Cases
No Result
View All Result
  • Opinion
    • Editorial
    • Commentaries
    • Letters
    • Comments
  • Current Affairs
    • Singapore
    • Malaysia
    • Indonesia
    • China
    • ASEAN
    • Asia
    • International
  • Finance
    • Economics
    • Labour
    • Property
    • Business
  • Community
    • Arts & Culture
    • Consumer Watch
    • NGO
    • Lifestyle
    • Travel
  • Politics
    • Civil Society
    • Parliament
    • Transport
    • Education
    • Environment
    • Health
    • Housing
  • Law & Order
    • Legislation
    • Court Cases
No Result
View All Result
The Online Citizen Asia
No Result
View All Result

WHO approves China’s Sinovac COVID vaccine

by The Online Citizen
02/06/2021
in Health
Reading Time: 3 mins read
13
过去五年  四成上班族曾遭性骚扰!仅30%受害者举报

The World Health Organization on Tuesday approved the Sinovac COVID-19 vaccine for emergency use — the second Chinese jab to receive the WHO’s green light.

The UN health agency signed off on the Beijing-based firm Sinovac’s two-dose vaccine CoronaVac, which is already being deployed in several countries around the world.

“I’m happy to announce that the Sinovac-CoronaVac vaccine has been given WHO emergency use listing after being found to be safe, effective, and quality-assured,” WHO chief Tedros Adhanom Ghebreyesus told a press conference.

“The easy storage requirements of CoronaVac make it very suitable for low-resource settings,” he added.

“It’s now crucial to get these life-saving tools to the people that need them quickly.”

The WHO said the emergency use listing (EUL) gives countries, funders, procuring agencies and communities assurance that the vaccine has met international standards.

Last month Sinopharm became the first Chinese vaccine to be approved by the WHO.

The organisation has also given EUL status to vaccines being made by Pfizer/BioNTech, Moderna, Johnson & Johnson, and the AstraZeneca jab being produced in India, South Korea and the EU, which it counts separately.

WHO’s listing paves the way for countries worldwide to approve and import a vaccine for distribution quickly, especially those states without an international-standard regulator of their own.

It also opens the door for the jabs to enter the Covax global vaccine-sharing facility, which aims to provide equitable access to doses around the world, particularly in poorer countries.

Currently only AstraZeneca and some Pfizer jabs are flowing through the scheme.

“The world desperately needs multiple Covid-19 vaccines to address the huge access inequity across the globe,” said Mariangela Simao, the WHO’s assistant director general for access to health products.

“We urge manufacturers to participate in the Covax facility, share their know-how and data and contribute to bringing the pandemic under control.”

Efficacy rate 

“WHO recommends the vaccine for use in adults 18 years and older, in a two-dose schedule with a spacing of two to four weeks,” the agency said in a statement.

“Vaccine efficacy results showed that the vaccine prevented symptomatic disease in 51 percent of those vaccinated and prevented severe COVID-19 and hospitalisation in 100 percent of the studied population.”

The Sinovac vaccine contains an inactivated form of coronavirus that cannot cause the disease. It also has a substance that helps strengthen the immune response to the vaccine.

When given the shot, the immune system identifies the inactivated virus as foreign and makes antibodies against it, which will then recognise the active virus and defend the body against it.

Few people aged over 60 took part in the clinical trial of Sinovac’s jab.

However, the WHO said there should be no upper age limit on the vaccine as there is “no reason to believe it has a different safety profile” in older generations.

The Sinovac jab is already in use in 22 territories around the world, according to an AFP count.

Apart from China, the countries using Sinovac include Chile, Brazil, Indonesia, Mexico, Thailand and Turkey.

Chen Xu, China’s ambassador in Geneva, said CoronaVac’s EUL status expanded the number of global tools to fight the pandemic.

“China will continue to work with the international community to promote the accessibility and affordability of COVID-19 vaccines especially in (the) developing world,” he said in a tweet.

— AFP

For just US$7.50 a month, sign up as a subscriber on The Online Citizen Asia (and enjoy ads-free experience on our site) to support our mission to transform TOC into an alternative mainstream press.
Source: AFP
Tags: AFPCOVID-19SinovacWHO

Related Posts

US businesses ‘fear internet curbs in Hong Kong’
AFP

Hong Kong offers free flights after COVID isolation

02/02/2023
US tells vaccinated people in high COVID risk areas to mask again
AFP

White House says US COVID emergency status to end 11 May

31/01/2023
WHO panel in talks on COVID emergency status
AFP

WHO panel in talks on COVID emergency status

27/01/2023
Zero-COVID left in dust as Chinese revellers fuel travel boom
AFP

Zero-COVID left in dust as Chinese revellers fuel travel boom

19/01/2023
China ends quarantine for overseas travellers after years of self-imposed isolation
AFP

China back to ‘normal’ after end of COVID curbs: official

17/01/2023
UK health firm estimates 9,000 COVID deaths in China per day but Chinese govt says only 10 since 7 Dec
AFP

‘Not necessary’ to dwell on COVID death tally, Chinese experts say

11/01/2023
Subscribe
Connect withD
Login
I allow to create an account
When you login first time using a Social Login button, we collect your account public profile information shared by Social Login provider, based on your privacy settings. We also get your email address to automatically create an account for you in our website. Once your account is created, you'll be logged-in to this account.
DisagreeAgree
Notify of
Connect withD
I allow to create an account
When you login first time using a Social Login button, we collect your account public profile information shared by Social Login provider, based on your privacy settings. We also get your email address to automatically create an account for you in our website. Once your account is created, you'll be logged-in to this account.
DisagreeAgree
13 Comments
Newest
Oldest Most Voted
Inline Feedbacks
View all comments

Latest posts

Ministers get away with excuses that ordinary citizens cannot hope to get away with

Ministers get away with excuses that ordinary citizens cannot hope to get away with

07/02/2023
Commemorative coin, exhibitions and various activities to mark 100th anniversary of Lee Kuan Yew’s birth

Commemorative coin, exhibitions and various activities to mark 100th anniversary of Lee Kuan Yew’s birth

07/02/2023
国会内庆妇女节 女议员获赠鲜花

15 companies barred from hiring new foreign employees after serious safety lapse found at worksite

07/02/2023
Why is Gautam Adani’s Indian empire in turmoil?

India’s Adani Enterprises shares rocket 20%, trading suspended

07/02/2023
China’s Baidu says developing AI chatbot

China’s Baidu says developing AI chatbot

07/02/2023
Thai rescuers dig to free baby trapped down well

Thai rescuers dig to free baby trapped down well

07/02/2023
Desmond Lee says 70% of BTO flats affordable for median household with income of S$8,400 but what about the 10th to 40th percentile?

Desmond Lee says 70% of BTO flats affordable for median household with income of S$8,400 but what about the 10th to 40th percentile?

07/02/2023
Returning Officer to issue corrective directions, overseas Singaporeans allowed to vote by post, among changes to laws tabled to Parliament

Returning Officer to issue corrective directions, overseas Singaporeans allowed to vote by post, among changes to laws tabled to Parliament

07/02/2023

Trending posts

Cognizant India transfers staff to work in Singapore as recently as this year

Local IT grads can’t find jobs while engineers constantly transferred from India to work in SG under CECA

by Correspondent
05/02/2023
106

...

They have done a fine job of confusing us about the jobs situation

They have done a fine job of confusing us about the jobs situation

by Augustine Low
01/02/2023
47

...

Adani’s brother runs SG company and registers as director with local ID

Adani’s brother runs SG company and registers as director with local ID

by Correspondent
03/02/2023
26

...

No response from Josephine Teo on whether Mediacorp has been instructed to stop coverage of SMT circulation scandal

No response from Josephine Teo over alleged blackout of coverage by Mediacorp over SMT circulation scandal

by Terry Xu
06/02/2023
12

...

Former Singaporean shares change of life in Australia with annual pay of S$80,000 as a plumber

Former Singaporean shares change of life in Australia with annual pay of S$80,000 as a plumber

by Yee Loon
30/01/2023
25

...

Japanese-Canadian junior high school girl breaks national record with 3km in 9:02 mins

“I want my normal life back,” Sherry Drury withdraws from National Junior High School Tournament due to overheated public attention

by Yee Loon
06/02/2023
3

...

June 2021
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
« May   Jul »

The Online Citizen is a regional online publication based in Taiwan and formerly Singapore’s longest-running independent online media platform.

Navigation

  • Editorial
  • Commentaries
  • Opinion
  • Politics
  • Community

Support

  • Contact Us
  • Letter submission
  • Membership subscription

Follow Us

  • Facebook
  • Twitter
  • YouTube
  • Instagram
  • Fact Checking Policy
  • Privacy Policy

© 2022 - 2023 The Online Citizen Asia

No Result
View All Result
  • Opinion
    • Editorial
    • Commentaries
    • Comments
  • Current Affairs
    • Malaysia
    • Indonesia
    • China
    • ASEAN
    • Asia
    • International
  • Finance
    • Economics
    • Labour
    • Property
    • Business
  • Community
    • Civil Society
    • Arts & Culture
    • Consumer Watch
    • NGO
  • Politics
    • Parliament
    • Transport
    • Education
    • Environment
    • Health
    • Housing
  • Law & Order
    • Legislation
    • Court Cases
  • Lifestyle
    • Travel
  • Subscribers login

© 2022 - 2023 The Online Citizen Asia

wpDiscuz